Mean_plasma_bicalutamide_levels_with_10_to_600_mg_per_day_bicalutamide_in_men.png

Summary

Description	English: I made this, anyone can use it. Created from source material using WebPlotDigitizer and Plotly . Sources of the values: (2004). "Bicalutamide: clinical pharmacokinetics and metabolism". Clinical Pharmacokinetics 43 (13): 855–878. DOI : 10.2165/00003088-200443130-00003 . PMID 15509184 . (1998). "Casodex 10-200 mg daily, used as monotherapy for the treatment of patients with advanced prostate cancer. An overview of the efficacy, tolerability and pharmacokinetics from three phase II dose-ranging studies. Casodex Study Group". Eur. Urol. 33 (1): 39–53. DOI : 10.1159/000019526 . PMID 9471040 . (2006). "Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration". BJU Int. 98 (3): 563–72. DOI : 10.1111/j.1464-410X.2006.06275.x . PMID 16771791 .
Date	5 July 2018
Source	Own work
Author	Medgirl131

I, the copyright holder of this work, hereby publish it under the following license:

You are free:

Under the following conditions:

attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
share alike – If you remix, transform, or build upon the material, you must distribute your contributions under the same or compatible license as the original.